Comparing the Top Two: Auris Medical Holding AG (NASDAQ:EARS), Himax Technologies, Inc. (NASDAQ:HIMX)

nyse

Auris Medical Holding AG (NASDAQ:EARS)

Auris Medical Holding AG (NASDAQ:EARS) closed at $1.43 on the last trading session with an decrease of -1.61%, whereas, it previously closed at $1.45. The company has a market capitalization of $4.79 Million. The company traded shares of 52147 on the trading day while its three month average volume stands at 150.49 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Auris Medical Holding AG (NASDAQ:EARS) produced diluted EPS of -7.1. The EPS estimate for next year as estimated by analysts is at -3.29 while EPS for next quarter is estimated at -1.64. Earnings per Share growth for this year is reported at 87, while the analysts estimated the EPS growth for next year at -3.29% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 34.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Auris Medical Holding AG (NASDAQ:EARS) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Auris Medical Holding AG (NASDAQ:EARS) stands at 0 and Price to Book or P/B for the most recent quarter stands at 0.34. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Auris Medical Holding AG (NASDAQ:EARS) are reported at 3.5 and 3.5 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Auris Medical Holding AG (NASDAQ:EARS) stands at -110.7, -494.5 and 0 respectively

The trailing twelve month Revenue of Auris Medical Holding AG (NASDAQ:EARS) is reported at 0 with income of -10500000. The outstanding shares of Auris Medical Holding AG (NASDAQ:EARS) are 3.36 Million. The institutional Ownership of the shares of 13.9 stands at 0.80%, this figure is increased 4.94 in the last six months. The insider ownership for the shares of Auris Medical Holding AG (NASDAQ:EARS) is ticked at 11.82%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Auris Medical Holding AG (NASDAQ:EARS) is the Mean Target Price estimated by the analysts which stands at 14.23. The 52 week high of Auris Medical Holding AG (NASDAQ:EARS) is placed at 9.40 and 52 week low is standing at 1.30.

Performance wise the shares of Auris Medical Holding AG (NASDAQ:EARS) rose up 1.91% for the week, it also fell -2.95% for the monthly performance, while for the quarter it went up -3.76%. The shares decrease -47.35% for the half year and plummeted for the Year-To-Date performance. The shares of Auris Medical Holding AG (NASDAQ:EARS) shrinked -81.9% for the yearly performance.

Himax Technologies, Inc. (NASDAQ:HIMX)

Himax Technologies, Inc. (NASDAQ:HIMX) closed at $4.88 on the last trading session with an increase of 4.05%, whereas, it previously closed at $4.69. The company has a market capitalization of $916.81 Million. The company traded shares of 3.94 Million on the trading day while its three month average volume stands at 1.52 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Himax Technologies, Inc. (NASDAQ:HIMX) produced diluted EPS of -0.15. The EPS estimate for next year as estimated by analysts is at -0.07 while EPS for next quarter is estimated at -0.02. Earnings per Share growth for this year is reported at -73.4, while the analysts estimated the EPS growth for next year at -0.07% and Earnings growth for next 5 years stands at 25% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -34.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Himax Technologies, Inc. (NASDAQ:HIMX) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Himax Technologies, Inc. (NASDAQ:HIMX) stands at 1.33 and Price to Book or P/B for the most recent quarter stands at 0.98. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Himax Technologies, Inc. (NASDAQ:HIMX) are reported at 1.1 and 1.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Himax Technologies, Inc. (NASDAQ:HIMX) stands at -0.7, -1.4 and 0.2 respectively

The trailing twelve month Revenue of Himax Technologies, Inc. (NASDAQ:HIMX) is reported at 687.9 Million with income of -7400000. The outstanding shares of Himax Technologies, Inc. (NASDAQ:HIMX) are 187.87 Million. The institutional Ownership of the shares of 7.7 stands at 0.80%, this figure is decreased -0.43 in the last six months. The insider ownership for the shares of Himax Technologies, Inc. (NASDAQ:HIMX) is ticked at 12.3%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Himax Technologies, Inc. (NASDAQ:HIMX) is the Mean Target Price estimated by the analysts which stands at 3.46. The 52 week high of Himax Technologies, Inc. (NASDAQ:HIMX) is placed at 4.82 and 52 week low is standing at 1.70.

Performance wise the shares of Himax Technologies, Inc. (NASDAQ:HIMX) rose up 4.72% for the week, it also rise 24.81% for the monthly performance, while for the quarter it went down 78.75%. The shares increase 133.49% for the half year and flew up for the Year-To-Date performance. The shares of Himax Technologies, Inc. (NASDAQ:HIMX) grew 26.1% for the yearly performance.